Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBIT Margin (2017 - 2020)

Historic EBIT Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 18333.01%.

  • Cogent Biosciences' EBIT Margin fell 171530100.0% to 18333.01% in Q3 2020 from the same period last year, while for Dec 2020 it was 1044.33%, marking a year-over-year decrease of 9013100.0%. This contributed to the annual value of 1044.33% for FY2020, which is 9013100.0% down from last year.
  • Latest data reveals that Cogent Biosciences reported EBIT Margin of 18333.01% as of Q3 2020, which was down 171530100.0% from 1402.08% recorded in Q2 2020.
  • Cogent Biosciences' 5-year EBIT Margin high stood at 14.65% for Q4 2019, and its period low was 18333.01% during Q3 2020.
  • Over the past 4 years, Cogent Biosciences' median EBIT Margin value was 332.18% (recorded in 2017), while the average stood at 1640.08%.
  • Examining YoY changes over the last 5 years, Cogent Biosciences' EBIT Margin showed a top increase of 3005100bps in 2020 and a maximum decrease of -171530100bps in 2020.
  • Quarter analysis of 4 years shows Cogent Biosciences' EBIT Margin stood at 324.07% in 2017, then rose by 27bps to 236.64% in 2018, then skyrocketed by 106bps to 14.65% in 2019, then tumbled by -125223bps to 18333.01% in 2020.
  • Its EBIT Margin was 18333.01% in Q3 2020, compared to 1402.08% in Q2 2020 and 87.34% in Q1 2020.